SiMPore Awarded Phase I SBIR From NIH To Improve TEM Imaging Technology For Biomedical Researchers

SiMPore Inc., an early-stage nanotechnology company in Rochester, NY, has received a Phase I SBIR grant from the National Institutes of Health to improve phase contrast transmission electron microscopy.

Related Posts

Comments are closed.